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Sport-Caught Fish
and Breast Cancer
Angling for More Data
The U.S. Food and Drug Administration
inspects fish sold at market for environ-
mental contaminants and removes tainted
seafood from sale. But consumption of
sport-caught fish by fishing enthusiasts and
those with whom they share their catch
may expose these people to chemicals that
affect development of breast cancer in some
women, according to a study by University
of Wisconsin Comprehensive Cancer
Center staff scientist Jane McElroy and col-
leagues [EHP 112:156–162].
Despite advisories warning anglers
away from contaminated fishing spots,
consumption of sport-caught fish remains
an important route of human exposure to
halogenated hydrocarbons thought to be
risk factors for breast cancer. Several of
these agents—including polychlorinated
biphenyls (PCBs), oily liquids not manufactured since the 1970s
but once used as industrial lubricants and coolants; the
U.S.–banned pesticide DDT and its most stable metabolite, DDE;
and polybrominated diphenyl ethers (PBDEs), which are currently
used as flame retardants in textiles, furniture, and other household
and office items—accumulate in lake fish. And although recall of
eating behaviors over time is imperfect, studies have shown that
self-reported histories of the amount of fish consumed correlate
with body burdens of PCBs, DDT/DDE, and PBDEs.
McElroy’s group has been studying risk factors related to breast
cancer as part of an ongoing population-based case–control study.
Along with fish consumption, the researchers are also looking at how
factors such as physical activity, family history, alcohol consumption,
hormone use, and reproductive history impact a woman’s chances of
developing breast cancer. 
The team used telephone interviews of patients newly diag-
nosed with the disease between 1998 and 2000 to gather data on
1,481 Wisconsin women aged 20–69. A control group of 1,301
randomly selected Wisconsin women with a similar age distribu-
tion also was interviewed. The women were asked how often they
ate sport-caught fish—and whether any of this fish had been
caught in the Great Lakes—over a 12-month period five years
before the interviewee’s cancer diagnosis or five years before a con-
trol’s matched reference age. 
Consistent with other studies, the survey revealed that the
women with breast cancer had gained more weight after age 18 than
women without. They were also, as a group, younger at menarche
and older at menopause, and were more likely to be older at first full-
term pregnancy, consume more alcohol, and have a family history of
breast cancer. But women with breast cancer and their age-matched
controls were similarly likely to have eaten sport-caught fish, from
the Great Lakes as well as from other fishing spots. 
Overall, the team found that sport-caught fish consumption was
not associated with breast cancer risk in Wisconsin women. But there
were two potentially troubling findings specifically regarding pre-
menopausal women under age 40: those who ate any sport-caught
fish had almost double the risk of developing breast cancer, and those
who ate Great Lakes sport-caught fish had a 74% greater risk. 
Although the study makes the link between cancer and consump-
tion of sport-caught fish—a food potentially high in PCBs,
DDT/DTE, and PBDEs—no link was drawn to the chemicals them-
selves. Understanding whether and how these chemicals are involved
in breast cancer among women who eat sport-caught fish will require
more direct analysis of their concentrations in affected individuals.
Still, the authors recommend, it is important to pay attention to the
effects of contamination of sport fisheries by these chemicals, espe-
cially PBDEs, which are still being manufactured and used in new
products. –Victoria McGovern
A New Mechanism for
Chlorpyrifos?
Implicating Serotonin
Organophosphate pesticides kill insects by allowing the neurotrans-
mitter acetylcholine to build up at nerve endings. This short-cir-
cuits the cholinergic system, which governs involuntary processes.
Low organophosphate doses given to rats in utero are associated
with neurodevelopmental effects and impaired behavior in adult
animals, and in the past, researchers assumed these adverse effects
arose from disruption of the cholinergic system. But recently Justin
E. Aldridge and colleagues at Duke University Medical Center
found that one organophosphate, chlorpyrifos, appears to affect
brain development through other, additional mechanisms, and at
doses lower than those that perturb the cholinergic system. Now
Aldridge and colleagues report that fetal and newborn rats exposed
to chlorpyrifos during particular developmental windows undergo
changes in their brain serotonin systems that persist into adulthood,
possibly contributing to the neurodevelopmental effects of this par-
ticular pesticide [EHP 112:148–155].
Chlorpyrifos was once one of the most widely used pesticides in
the United States. Due to concerns about its neurologic effects in
children, chlorpyrifos was banned from home and garden use in June
2000 under an agreement between the U.S. Environmental
Protection Agency and pesticide manufacturers. But it is still used in
the United States to protect commercial fruit and vegetable crops,
and worldwide it remains one of the most heavily used pesticides.  
Aldridge and colleagues injected pregnant rats daily with 1 or 5
milligrams of chlorpyrifos per kilogram body weight (mg/kg) for 3
Not-so-great lakes? New research raises concerns that sport-caught lake fish may contribute to high
contaminant exposures in women who eat it, with potential risks for breast cancer.Science Selections
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days either early (when the brain is first being formed) or late in ges-
tation. These doses bracket the threshold for maternal toxicity and
fetal cholinesterase inhibition. They also injected non–previously
exposed 1-week-old pups with 1 mg/kg and 2-week-old pups with 5
mg/kg over a 3-day period. 
The researchers allowed the young rats and the offspring of the
pregnant rats to mature, then harvested the adult aimals and mea-
sured biomarkers of serotonin system function in their dissected
brains. These biomarkers included a number of serotonin receptors
and transporters that the researchers had earlier found to be altered
shortly after chlorpyrifos exposure (see EHP 111:1736–1743 [2003]). 
Although statistically significant effects were seen at all exposure
intervals and for both doses, treatments during the late gestational
period and the first week after birth—a stage in the rat that parallels
the second trimester of human fetal development—had the maxi-
mum effects, with increases in receptors and transporters as great as
30–80% above control values in some brain regions. The greatest of
these elevations occurred in male rats in the striatum region, which is
generally thought to be involved with motor control. 
It appears that later in development, the treatment affects males
more than females. Other studies of chlorpyrifos’s neurodevelopmen-
tal effects also have found that sex differences emerged only when
exposure occurred late in gestation or in the neonatal period, but
those studies did not follow rats to adulthood, nor did they focus on
serotonin disruption by chlorpyrifos.
The authors suggest that perturbations in cell differentiation and
brain architecture may be one of the contributors to noncholinergic
mechanisms of chlorpyrifos-induced neurobehavioral anomalies.
Because serotonin is involved in controlling appetite and modulating
depression, these results also lend support to the idea that environ-
mental exposures may increase the risk of these problems, according
to the authors. –Rebecca Renner
The Danger of Extrapolation
Humans and Rodents Differ in Response to PCBs
Although awareness of the extreme toxicity of
polychlorinated biphenyls (PCBs) led to their
1976 ban in the United States, these chemicals’
virtually indestructible molecular nature and
environmental ubiquity make them a continu-
ing serious health threat. Much of what we
know about the health effects of PCBs comes
from rodent studies, and current thinking in
toxicology and risk analysis is based on the
assumption that results in animal models will
extrapolate to humans. This month, Michelle
M. Tabb of the University of California, Irvine,
and colleagues report on an investigation com-
paring human biological response to PCB expo-
sure to that of rodents [EHP 112:163–169].
Their findings indicate there are significant
physiological differences between humans and
rats that have important implications for risk
assessment.
Highly stable and flame-resistant, PCBs have
long been used in the manufacture of industrial
products such as electrical insulation, machinery
lubricants, plastics, wood products, paints, inks,
and agricultural pesticides. Although PCBs are no
longer made in the United States, their long-
term, widespread use and persistence in the envi-
ronment have made them virtually ubiquitous in
soil, water, and air today. PCBs accumulate in animal liver and fat
tissue. They disrupt normal hormonal functioning and cause brain
and nervous system damage, cancer, and other health problems. 
Scientists already knew that when PCBs bind to the pregnane X
receptor (PXR) in rodents, the ligand-bound receptor elicits produc-
tion of enzymes that metabolize PCBs and other contaminants. The
current study was a comparative investigation to determine what
happens when PCBs bind to the human counterpart to PXR—the
steroid and xenobiotic receptor (SXR). 
The research design incorporated multiple approaches to evaluate
reactions from exposure of human and rat cells to at least 26 different
PCBs in separate assays. Activation assays tested the ability of the
compounds to activate mRNA transcription of the receptor in trans-
fected cells. The authors used Northern blots to compare the amount
of mRNA produced in exposed versus control cells. In another type
of test, RNA isolated from exposed cells was converted to cDNA and
amplified by QRT-PCR (quantitative real-time reverse transcriptase
polymerase chain reaction) to quantify gene expression. 
The scientists discovered that the most stable and abundant
PCBs found in human tissues activated PXR and induced expression
of target genes for metabolizing the toxicants, producing a protective
physiological reaction in rodents. In contrast, these same PCBs
antagonized SXR, blocking the expression of target genes and
inhibiting the human body’s ability to physiologically counteract
harmful effects of exposure (several less stable PCBs did not antago-
nize SXR, however). They also found that PCBs were able to increase
the amount of a key metabolic enzyme in rat liver cells but not in
human liver cells. QRT-PCR analysis showed that treatment with
antagonistic PCBs reduced the expression of genes encoding key
metabolic enzymes in human cells, confirming the results of the acti-
vation assays and Northern blots.
The demonstration that many PCBs block SXR in humans
rather than activate it—as previously thought, based on animal
models—challenges the assumption that animal models extrapolate
to humans. This discovery brings important new insight for devel-
opment of sound, rational, science-based public policy to protect
human health. –Mary Eubanks
Mice are not men.Data showing that humans and rodents differ significantly in their response to
PCBs raise doubts about the accuracy of extrapolating from some animal models in toxicology.